Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy.

By P. Pappas, J. Perfect, G. Cloud, R. Larsen, G. Pankey, D. Lancaster, H. Henderson, C. Kauffman, D. Haas, M. Saccente and 4 more. Clinical Infectious Diseases, 2001

632 citations recorded by the source corpus.

Subfields: Epidemiology, Infectious Diseases

View Paper: https://www.semanticscholar.org/paper/881dab06e44cc3b278cd486cf102c040d17dba54

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. M. Pfaller
2. D. Diekema
3. J. Perfect
4. Nina Singh
5. J. Guinea

In Infectious Diseases

1. M. Pfaller
2. D. Diekema
3. J. Perfect
4. Nina Singh
5. J. Guinea

Citations in the corpus

• Epidemiology of Invasive Mycoses in North America (2010, background): “2006); however, both local and disseminated infections are observed in patients with no known immunologic defect (Mirza et al. 2003; Mitchell et al. 1995; Pappas et al. 2001).”
• Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America (2010, methodology): “Corticosteroid treatment may be considered if ARDS is present in the context of IRIS (B-III).”